directed evolution of enantioselective biocatalysts · directed evolution of baeyer villigerases...
TRANSCRIPT
Directed Evolution of Stereoselective Biocatalysts
David KnappCHEM575 Literature Seminar
3-13-2008
Importance of Stereoselective Synthesis
Catalytic Approaches
Small Molecules Enzymes
•High substrate scope•Stability/Solubility•Synthetic accessibility•Decades of development
•Poor solubility/stability•Greener chemistry•Tremendous complexity•Excellent stereoselectivity
How can we get better enzymatic catalysts?
Cloning naturalenzymes De novo design
Rational modification
Directed evolution
Directed Evolution
RandomMutagenesis
Transformation &Expression
Selection /Screening
Cloned DNA
Mutagenesis Methods
DNA Shuffling
Error Prone PCR (epPCR)Taq
MnCl2Cloned DNA
Cadwell, R. C.; Joyce, G. F. PCR Methods Appl. 1994, 3, 136-140.Soi, C. F.; et al. Eur. J. Biochem. 2002, 269, 4495-4504.Stemmer, W. P. C. Proc. Natl. Acad. Sci. 1994, 91, 10747-10751.
Primer
Site Saturation MutagenesisRandomizedPrimers
*
The Sorting Problem
SelectionScreeningEfficientScalableNot SimpleNot General
Brute ForceTime/Labor/Resource IntensiveSimpleGeneral
Large Libraries:Good for diversity, Bad for sorting
Taylor, S. V.; Kast, P; Hilvert, D. Angew. Chem. Int. Ed. 2001, 40, 3310-3335.
Solutions to the Sorting ProblemSelection
Water insoluble Water soluble
Taylor, S. V.; Kast, P; Hilvert, D. Angew. Chem. Int. Ed. 2001, 40, 3310-3335.Reetz, M. T. Angew. Chem. Int. Ed. 2001, 40, 284-310.
Chorismate Mutase Libraries expressed in cells lacking Chorismate Mutase
prephenate
Solutions to the Sorting Problem
SpectroscopyUV-visFluorescence
Chiral ChromatographyHPLCGC
Capillary ElectrophoresisInfrared Thermogenic ImagingCircular DichroismMass Spectrometry
Screening
Reetz, M. T. Angew. Chem. Int. Ed. 2001, 40, 284-310.
• Involves analysis of reaction products
• Throughput is key!
Successful examples
Baeyer Villiger Oxidation
Reetz, M. T., et. al. Angew. Chem. Int. Ed. 2004, 43, 4075-4078.
Mechanism
Chiral Products
Enzymatic Baeyer Villiger Oxidation
Reetz, M. T., et al. Angew. Chem. Int. Ed. 2004, 43, 4075-4078.
Cyclohexanone Monooxygenase (CHMO)
Directed Evolution of Baeyer Villigerases
• Mutagenesis StrategyepPCR – 10,000 in round 1
2,000 in round 2
• ScreeningChiral GC – 800 variants/day
• Libraries expressed in E. coli.
• Screen reaction run with whole cells
Reetz, M. T., et al. Angew. Chem. Int. Ed. 2004, 43, 4075-4078.
Directed Evolution of Baeyer Villigerases
Reetz, M. T., et al. Angew. Chem. Int. Ed. 2004, 43, 4075-4078.
First round hits
O
OH
O2
CHMOmutants
OO
H OH
(R)-3OO
H OH
(S)-3
+
Results of Directed Evolution
Reetz, M. T., et al. Angew. Chem. Int. Ed. 2004, 43, 4075-4078.
Improved R Variant
Substrate Scope
Conclusions from Reetz Study
How is this study significant?
•Unselective enzyme made synthetically useful •Significant reversal of stereoselectivity• Simplistic mutagenic strategy• Substrate scope• Prior knowledge requirements•Superiority to other approaches
N-acetylneuraminic lyase (NAL)
Williams, G. J., et al. J. Am.. Chem. Soc. 2006, 128, 16238-16247.
Sialic acidsWild type NAL (S:R) = 74:26
(Aldolase)
Directed Evolution of NAL
Williams, G. J., et al. J. Am.. Chem. Soc. 2006, 128, 16238-16247.
• Mutagenesis StrategyepPCR – 2500/roundsite-saturation mutagenesissemi-rational design
• Screening
Pr2NO
OH
OH
OMe CO2
OO
OAcHN
OH
CO2
OHPr2N O
OAcHN
OH
CO2Pr2N
OH
++
lactatedehydrogenase
NADHNAD+
Me CO2
OH+
NAL
variant
Structural Considerations
Williams, G. J., et al. J. Am.. Chem. Soc. 2006, 128, 16238-16247.
4R-selectiveRed
4S-selectiveGreen
Directed Evolution of NAL
Williams, G. J., et al. J. Am.. Chem. Soc. 2006, 128, 16238-16247.
4S-product4R-productaldehyde
Best4S-Selective
Best4R-Selective
66% Yieldd.r. >98:2
70% Yieldd.r. >98:2
Structural Considerations
Williams, G. J., et al. J. Am.. Chem. Soc. 2006, 128, 16238-16247.
4R-selectiveE192NT167VS208V
4S-selectiveE192NT167G
Substrate analog
Evolution of an Enantioselective Aldolase
deoxy-D-ribose 5-phosphate aldolase (DERA)
Proposed Application
• e.r. > 99.9:0.1• Low activity• Limited substrate scope• Substrate Inhibition
Lys
Gijsen, H. J. M.; Wong, C. H. J. Am. Chem. Soc. 1994, 116, 8422‐8423.Greenberg, W. A., et al. PNAS 2004, 101, 5788‐5793.
Directed Evolution of an EnantioselectiveAldolase
•GoalsImprove the activity of DERADecrease substrate inhibition
•Mutagenesis StrategyepPCR – 3,000 clones per roundDNA Shuffling of best hits
• ScreeningTarget reaction run in cell free extractActivity determined by GCThroughput: 300 samples/day
Jennewein, S., et al. Biotechnol. J. 2006, 1, 537-548.
Results of Directed Evolution
Best Hits Displayed:• Increased activity• Reduced substrate inhibition
Jennewein, S., et al. Biotechnol. J. 2006, 1, 537-548.
DE of an Enantioselective Aldolase
Jennewein, S., et al. Biotechnol. J. 2006, 1, 537-548.
Atorvastatin (Lipitor)
N OH
OOHOHMeMe
O
NH
F
N OH
OOHOHMeMe
O
NH
F
•Statin•Inhibits HMG-CoA-Reductase•Marketed by Pfizer•2006 Sales: $12.9 billion
Hu, S.; Tao, J.; Xie, Z. PCT Int. Appl. 2006, 34pp, WO 2006134482 A1.“Pfizer wins Lipitor Patent Extension”, myiRIS, 4-3-2007.
Single-Enantiomer Synthesis
Conclusions
Directed Evolution stands as an underutilized, yet potentially general and powerful way to access stereoselective catalysts
BenefitsExceptional catalyst stereoselectivityMethodological complementarity to transition metalsStrategic generalityGreen chemistry
LimitationsCurrent enzymatic scope/availabilityOverhead
Future Directions
• Professor Silverman• Professor Burke• The Burke Group• CHEM575 Class
Acknowledgements